We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$89.3B
AUM Growth
+$8.23B
(+10%)
Cap. Flow
+$1.9B
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,235
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$60.1M |
| 2 |
TSMC
TSM
|
+$59.1M |
| 3 |
Tesla
TSLA
|
+$56M |
| 4 |
Apple
AAPL
|
+$55.2M |
| 5 |
Amazon
AMZN
|
+$47.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$102M |
| 2 |
Everest Group
EG
|
+$27.4M |
| 3 |
Chevron
CVX
|
+$25M |
| 4 |
Wells Fargo
WFC
|
+$24.9M |
| 5 |
Crane NXT
CXT
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.27% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $2.17M | ﹤0.01% |
54,683
+1,462
| +3% | +$54.9K |
|
1852
James River Group Holdings
JRVR
$217M
| $2.16M | ﹤0.01% |
118,303
-2,467
| -2% | -$49.1K |
|
1853
Ameresco
AMRC
$1.36B
| $2.16M | ﹤0.01% |
44,401
+1,033
| +2% | +$46.5K |
|
1854
Seaboard Corp
SEB
$4.06B
| $2.16M | ﹤0.01% |
606
+55
| +10% | +$209K |
|
1855
SunCoke Energy
SXC
$797M
| $2.15M | ﹤0.01% |
273,750
-1,189
| -0.4% | -$9.33K |
|
1856
Cohen & Steers
CNS
$4.3B
| $2.15M | ﹤0.01% |
37,125
+2,238
| +6% | +$131K |
|
1857
Protagonist Therapeutics
PTGX
$9.44B
| $2.15M | ﹤0.01% |
77,911
+3,202
| +4% | +$80.1K |
|
|
CHCT
1858
Community Healthcare Trust
CHCT
$454M
| $2.14M | ﹤0.01% |
64,766
+1,415
| +2% | +$49.2K |
|
1859
Eagle Bancorp
EGBN
$845M
| $2.14M | ﹤0.01% |
100,983
-2,893
| -3% | -$68.1K |
|
1860
Korea Electric Power
KEP
$16B
| $2.14M | ﹤0.01% |
+275,545
| New | +$1.98M |
|
1861
TriMas Corp
TRS
$1.44B
| $2.13M | ﹤0.01% |
77,518
+9,215
| +13% | +$243K |
|
|
LADR
1862
Ladder Capital
LADR
$1.24B
| $2.13M | ﹤0.01% |
196,398
+12,141
| +7% | +$118K |
|
1863
Bank of N.T. Butterfield & Son
NTB
$2.45B
| $2.13M | ﹤0.01% |
77,812
-986
| -1% | -$25.6K |
|
|
AAMI
1864
Acadian Asset Management
AAMI
$3.19B
| $2.13M | ﹤0.01% |
101,463
+5,487
| +6% | +$122K |
|
1865
Alphatec Holdings
ATEC
$1.44B
| $2.12M | ﹤0.01% |
118,027
+17,877
| +18% | +$278K |
|
|
OSG
1866
Octave Specialty Group
OSG
$222M
| $2.12M | ﹤0.01% |
148,532
+916
| +0.6% | +$13.4K |
|
|
EVRI
1867
DELISTED
Everi Holdings
EVRI
| $2.11M | ﹤0.01% |
146,162
+18,092
| +14% | +$275K |
|
|
HEES
1868
DELISTED
H&E Equipment Services
HEES
| $2.11M | ﹤0.01% |
46,130
+2,182
| +5% | +$87.2K |
|
1869
SFL Corp
SFL
$1.61B
| $2.11M | ﹤0.01% |
226,185
+8,857
| +4% | +$80.2K |
|
|
AVDX
1870
DELISTED
AvidXchange
AVDX
| $2.1M | ﹤0.01% |
202,563
+6,808
| +3% | +$61.2K |
|
1871
Regenxbio
RGNX
$708M
| $2.1M | ﹤0.01% |
105,122
+1,976
| +2% | +$38.1K |
|
|
SWTX
1872
DELISTED
SpringWorks Therapeutics
SWTX
| $2.1M | ﹤0.01% |
80,047
+22,056
| +38% | +$580K |
|
1873
Orthofix Medical
OFIX
$419M
| $2.1M | ﹤0.01% |
116,086
-5,899
| -5% | -$110K |
|
1874
Columbus McKinnon
CMCO
$584M
| $2.1M | ﹤0.01% |
51,540
+6,355
| +14% | +$235K |
|
|
VTYX
1875
DELISTED
Ventyx Biosciences
VTYX
| $2.09M | ﹤0.01% |
63,843
+30,952
| +94% | +$1.07M |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,235 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
- RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
- RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
- RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
- RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.